1.
Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus
by Fufaa, Gudeta D
Diabetologia, 2014-10-15, Vol.58 (1), p.188-198
2.
Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure
by NAKAMURA, T
Diabetologia, 2007, Vol.50 (2), p.490-492
3.
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus
by Roscioni, S. S
Diabetologia, 2013-02, Vol.56 (2), p.259-267
4.
Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)
by Agrawal, Lily
Diabetologia, 2017-11-03, Vol.61 (2), p.295-299
5.
Death, end-stage renal disease and renal function decline in patients with diabetic nephropathy in French cohorts of type 1 and type 2 diabetes
by Hadjadj, Samy
Diabetologia, 2015-10-20, Vol.59 (1), p.208-216
6.
Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria
by von Scholten, Bernt Johan
Diabetologia, 2016-03-31, Vol.59 (7), p.1549-1557
Filter electronic articles 6 Hits
Remove Filters
- Journal Title
- Diabetologia
